日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

UK approves antiviral treatment for COVID-19

By ANGUS McNEICE in London | China Daily Global | Updated: 2020-06-02 10:24
Share
Share - WeChat

The United Kingdom medicines regulator has approved the use of remdesivir, an antiviral drug that is thought to shorten the recovery time for COVID-19 patients.

The drug, which is developed by California-based pharmaceutical company Gilead Sciences, will only be used in adults and adolescents who are hospitalized with severe symptoms of novel coronavirus infection.

Early trials of the drug suggest it can improve the recovery time for patients with severe symptoms of COVID-19 by up to four days.

"This is probably the biggest step forward in the treatment of coronavirus since the crisis began," Health Minister Matt Hancock said at a UK government news conference. "These are very early steps, but we are determined to support the science and back the projects that show promise."

The UK's Medicines and Healthcare products Regulatory Agency, or MHRA, approved the drug under its Early Access to Medicines Scheme, or EAMS.The scheme was created to provide access to promising yet unlicensed drugs for patients with life threatening conditions.

"We are committed to ensuring that patients can have fast access to promising new treatments for COVID-19," said MHRA Chief Executive June Raine. "We will continue to work closely with the Department of Health and Social Care and other healthcare partners on protecting public health in the UK by prioritizing our essential work on clinical trials, access to medicines, and the development of vaccines."

Remdesivir was created in 2009 as a drug to treat hepatitis C. The drug showed limited efficacy against hepatitis, and similarly was ineffective against Ebola virus disease and Marburg virus infections.

However, the drug later showed promising results against several other viruses including coronaviruses.

Remdesivir has been used in several COVID-19 trials since January. Patients given remdesivir had a 31 percent shorter recovery time versus placebo, according to a study in April by the National Institutes of Health, which is an agency of the United States Department of Health.

That trial involved 1,063 hospitalized patients with advanced COVID-19 infection, and the median time to recovery was 11 days for patients on remdesivir, compared with 15 days for those without it.

"This shows fantastic progress," said James Bethell, who is parliamentary Under-Secretary of State for Innovation at the UK Department of Health and Social Care. "As we navigate this unprecedented period, we must be on the front foot of the latest medical advancements, while always ensuring patient safety remains a top priority. The latest, expert scientific advice is at the heart of every decision we make, and we will continue to monitor remdesivir's success in clinical trials across the country to ensure the best results for UK patients."

The drug has also been authorized for emergency use in the US and Japan.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 久久综合九色综合欧美播 | 天天透天天干 | 国产婷婷色一区二区三区在线 | 亚洲欧美国产日产综合不卡 | 日本在线观看 | 天堂资源av | 国产1区在线观看 | 欧洲另类一二三四区 | 国产精品久久久久一区二区 | 亚洲免费观看视频 | 羞羞色院91蜜桃在线观看 | 亚洲日韩中文字幕一区 | 午夜国产亚洲精品一区 | 国产999精品久久久久久 | 欧美亚洲 尤物久久 综合精品 | 成人欧美在线观看免费视频 | 久久久精品影院 | 午夜在线视频一区二区三区 | 91丨九色丨首页在线观看 | 91九色免费视频 | 国产色在线 | 视频一区二区在线观看 | 日韩一区二区三区精品 | 成人开心网 | 久久不卡一区二区三区 | 亚洲精品久久久 | 午夜理论电影在线观看亚洲 | 精品久久久久久久久久久久 | 激情五月社区 | 日韩中文字幕在线观看视频 | 波多野吉衣 免费一区 | 精品福利在线视频 | 国产精品吹潮在线观看中文 | 成人免费视频网站 | 九九热精品在线视频 | 成人国产免费视频 | 亚洲免费观看视频 | 欧美午夜艳片欧美精品 | 91色综合| 免费观看黄色a一级视频播放 | 国产原创视频在线 |